Question 1

A fully-funded Gavi will:

Accepted Answer

Reach 500 million children, saving 8–9 million lives from 2026–2030, including 50 million children with malaria vaccines and at least 120 million girls with the HPV vaccine, which protects against cervical cancer.
Reach more zero-dose children, with a goal to halve their number by 2030.
Deepen partnerships with countries, which will fund more than 40% of the costs of the vaccines themselves.
Make our largest-ever investment in health security, investing in programmes and stockpiles capable of responding to over 150 outbreaks.
Make over half the vaccines in our portfolio able to help countries adapt to the climate change and antimicrobial resistance.
Help countries improve their health systems to facilitate over 1.4 billion individual contacts – enabling more integrated primary health care and Universal Health Coverage.

Question 2

A fully-funded Gavi will

Accepted Answer

Reach 500 million children, saving 8–9 million lives from 2026–2030, including 50 million children with malaria vaccines and at least 120 million girls with the HPV vaccine, which protects against cervical cancer.
Reach more zero-dose children, with a goal to halve their number by 2030.
Deepen partnerships with countries, which will fund more than 40% of the costs of the vaccines themselves.
Make our largest-ever investment in health security, investing in programmes and stockpiles capable of responding to over 150 outbreaks.
Make over half the vaccines in our portfolio able to help countries adapt to the climate change and antimicrobial resistance.
Help countries improve their health systems to facilitate over 1.4 billion individual contacts – enabling more integrated primary health care and Universal Health Coverage.

Question 3

Protecting our world

Accepted Answer

Over the past 25 years, Gavi has not only protected a whole generation of children from disease, it has also helped to protect our entire world by preventing and responding to outbreaks of diseases that can easily spread across borders.
In the next five years, its role in the frontline of the world’s health security system will be even more important. Through routine immunisation,
Gavi helps to prevent outbreak-prone diseases such as measles.
Gavi is helping the world prepare for future pandemics by creating the US$ 2.5 billion Day Zero Financing Facility and making available up to US$ 1 billion for the African Vaccine Manufacturing Accelerator (AVMA).
Thanks to Gavi’s market-shaping efforts, production of cholera vaccines has increased 18-fold in the last decade.
By maintaining global stockpiles for other outbreak-prone diseases such as Ebola, yellow fever, meningitis and in future Mpox, Gavi is fighting on the front line to help keep deadly diseases at bay.
As a co-lead of COVAX, Gavi helped deliver 2 billion COVID-19 vaccine doses to 146 countries during the pandemic.

Question 4

Building partnerships, strengthening economies

Accepted Answer

Supporting Gavi is not just good for human health, it is also good for economic development and over 25 years Gavi has helped economies to grow and become self-sufficient. In the next five years, a fully funded Gavi will play an even more important role as countries face new and serious challenges.
With every dollar invested in Gavi generating 54 dollars/euros in wider economic benefits, Gavi’s work will generate US$ 100 billion of economic benefits for Gavi-supported countries from 2026–2030.
Half of Gavi’s vaccine portfolio will help countries adapt and respond to climate change and reduce the use of antibiotics.
Sharpening our focus on gender-related barriers will help us reach more zero-dose children and facilitate hundreds of millions of contacts between families and health services through routine vaccination.
Over the next five years, countries will make their largest ever investment in immunisation, paying almost 50% of the costs of their routine vaccines and placing them in the driving seat of their immunisation strategies.

Now is the time to

Step up